Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection.

To determine the role that cellular immune responses play in the protection conferred by vaccination with attenuated SIVmac32H (pC8), we have attempted to deplete macaques of their CD8(+) cells prior to challenge with wild-type SIVmac32H (pJ5), In two of four pC8-infected macaques, N109 and N112, a transient partial depletion of CD8(+) cells by antibody treatment was achieved. On the day of challenge peripheral CD2(+)CD4(-)CD8(+) cell counts were reduced by 92 and 95%, respectively, in animals N109 and N112 and their lymph nodes revealed a 46 and 58% reduction, respectively, in CD2(+)CD4(-)CD8(+) cells. Two other pC8-immunized macaques, N110 and N111, treated in the same way, did not show significant depletion of CD8(+) cells. None of these four pC8-immunized animals became infected when challenged with 50 MID50 Of pJ5, Treatment of a further four pC8-infected and protected macaques and two naive control animals with Campath-1H antibody successfully depleted peripheral CD3(+) cell counts by >99% in all treated animals. Campath-1H depletion resulted in enhanced, longer lasting lymphoid depletion. Yet subsequent challenge with 20 MID50 of pJ5 still failed to infect the pC8-immunized animals. All eight of the naive controls, including two Campath-1H-treated animals, became infected following challenge. In summary, partial depletion of circulating CD8(+) cells or total lymphocytes prior to challenge failed to abrogate the protection conferred by vaccination with pC8.